DBU: AN EFFICIENT BASE CATALYST
2667
2 H), 7.46 (m, 2 H40, 2 H), 7.31 (m, 2 H30, 2 H50, 4 H), 7.23 (m, 2 H20, 2 H60, 4H), 7.15
(m, H300, H500, 2H), 6.73 (d, H200, H600, 2H), 5.06 (s, CH, 1 H), 3.68 (s, CH3, 3 H); 13C
NMR (DMSO-d6, 100 MHz) d 170.27, 158.9 (C2), 154 (C3a), 150 (2 C, C7, C400), 114
(C7a), 140 (2 C, 2C10), 131 (2 C, C200, C600), 129 (4 C, 2C30, 2C50), 128.4 (4 C, 2 C20, 2
C60), 128.5 (C100), 127 (2 C, 2 C40), 110.86 (2C, C300, C500), 55 (CH3), 50 (CH); HR
MS: m=z calcd. for C25H21O2N4S MHþ 441.138; found 441.138; and m=z calcd.
for C25H19O2N4S M-Hþ 439.123; found 439.123.[12]
ACKNOWLEDGMENTS
This work is dedicated to Professor Han Zuilhof and Tom Wennekes of the
laboratory of Organic Chemistry at Wageningen University for their technical
assistance of this research.
SUPPLEMENTARY MATERIAL
REFERENCES
1. Freeman, F.; Kim, D. S. H. L. Preparation of 2-alkyl and 2-aryl-5-amino-4-cyano-1,3-
oxazoles. Tetrahedron Lett. 1989, 30, 2631–2632.
2. Freeman, F.; Chen, T.; Van Der Linden, J. B. Synthesis of highly functionalized 1,3-
oxazoles. Synthesis 1997, 861–862.
3. Ferris, J. P.; Orgel, L. E. Studies in prebiotic synthesis, I: Aminomalononitrile and
4-amino-5-cyanoimidazole. J. Am. Chem. Soc. 1966, 88, 3829.
4. Bauser, M.; Delapierre, G.; Hauswald, M.; Flessner, T.; D’Urso, D.; Hermann, A.;
Beyreuther, B.; De Vry, J.; Spreyer, P.; Reissmuller, E.; Meier, H. Discovery and optimi-
zation of 2-aryl oxazolo-pyrimidines as adenosine kinase inhibitors using liquid phase
parallel synthesis. Bioorg. Med. Chem. Lett. 2004, 14, 1997–2000.
5. Martin-Kohler, M.; Widmer, J.; Bold, G.; Meyer, T.; Sequin, U.; Traxler, P. Furo[2,3-d]-
pyrimidines and oxazolo[5,4-d]pyrimidines as inhibitors of receptor tyrosine kinases
(RTK). Helv. Chim. Acta 2004, 87, 956–975.
6. Holschbach, M. H.; Bier, D.; Stusgen, S.; Wutz, W.; Sihver, W.; Coenen, H. H.; Olsson,
¨
R. A. Synthesis and evaluation of 7-amino-2-(2(3)-furyl)-5-phenylethyl-amino-
oxazolo[5,4-d]pyrimidines as potential A2A adenosine receptor antagonists for positron
emission tomography (PET). Eur. J. Med. Chem. 2006, 41, 7–15.
7. Tolman, R. L.; Robins, R. K.; Townsend, L. B. Pyrrolopyrimidine nucleosides, III: Total
synthesis of toyocamycin, sangivamycin, tubercidin, and related derivatives. J. Am. Chem.
Soc. 1969, 91 (8), 2102–2108.
8. Patil, V. D.; Townsend, L. B. The synthesis of certain 2,7-disubstituted oxazolo[5,4-d]
pyrimidines. J. Heterocycl. Chem. 1971, 8, 503–505.
9. Bakavoli, M.; Heravi, M. M.; Germaninajad, H.; Rahimizadeh, M.; Ghassemzadeh, M.
Synthesis of a novel heterocyclic system: Oxazolo[3,2-c]pyrimidine. Phosphorus Sulfur
Relat. Elem. 2006, 181, 381–385.
10. Muthusamy, S.; Babu, S. A.; Gunanathan, C. 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU):
A powerful catalyst for the michael addition reaction of b-ketoesters to acrylates and
enones. Synth. Commun. 2002, 32 (21), 3247–3254.